Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose vitamin C plus disulfiram in advanced NSCLC not suitable for platinum chemotherapy
ChiCTR2500111613Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ascorbic acid and disulfiram in non-small cell lung cancer (NSCLC), sponsored by West China Hospital of Sichuan University. Primary endpoint: Progression-free survival. Started Dec 2025; status: recruiting.
02
Drugs
ascorbic aciddisulfiram
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2500111613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111613.